TY - JOUR
T1 - Nervous yeast
T2 - modeling neurotoxic cell death
AU - Braun, Ralf J.
AU - Büttner, Sabrina
AU - Ring, Julia
AU - Kroemer, Guido
AU - Madeo, Frank
N1 - Funding Information:
We are grateful to the German Research Foundation (DFG) for grant BR 3706/1-1 to R.J.B. (DFG post-doc fellowship), to the Austrian Science Fund (FWF) for grant T-414-B09 to S.B (Hertha-Firnberg fellowship), for grant S-9304-B05 to F.M., J.R. and S.B., and for grant “Lipotox” to F.M. and S.B., and to the European Commission for project APOSYS to F.M. and G.K.
PY - 2010/3/1
Y1 - 2010/3/1
N2 - Neurodegeneration is characterized by the disease-specific loss of neuronal activity, culminating in the irreversible destruction of neurons. Neuronal cell death can proceed via distinct subroutines such as apoptosis and necrosis, but the underlying molecular mechanisms remain poorly understood. Saccharomyces cerevisiae is an established model for programmed cell death, characterized by distinct cell death pathways conserved from yeast to mammals. Recently, yeast models for several major classes of neurodegeneration, namely α-synucleinopathies, polyglutamine disorders, β-amyloid diseases, tauopathies, and TDP-43 proteinopathies, have been established. Heterologous expression of the human proteins implicated in these disorders has unraveled important insights in their detrimental function, pointing to ways in which yeast might advance the mechanistic dissection of cell death pathways relevant for human neurodegeneration.
AB - Neurodegeneration is characterized by the disease-specific loss of neuronal activity, culminating in the irreversible destruction of neurons. Neuronal cell death can proceed via distinct subroutines such as apoptosis and necrosis, but the underlying molecular mechanisms remain poorly understood. Saccharomyces cerevisiae is an established model for programmed cell death, characterized by distinct cell death pathways conserved from yeast to mammals. Recently, yeast models for several major classes of neurodegeneration, namely α-synucleinopathies, polyglutamine disorders, β-amyloid diseases, tauopathies, and TDP-43 proteinopathies, have been established. Heterologous expression of the human proteins implicated in these disorders has unraveled important insights in their detrimental function, pointing to ways in which yeast might advance the mechanistic dissection of cell death pathways relevant for human neurodegeneration.
UR - http://www.scopus.com/inward/record.url?scp=77649163374&partnerID=8YFLogxK
U2 - 10.1016/j.tibs.2009.10.005
DO - 10.1016/j.tibs.2009.10.005
M3 - Review article
C2 - 19926288
AN - SCOPUS:77649163374
SN - 0968-0004
VL - 35
SP - 135
EP - 144
JO - Trends in Biochemical Sciences
JF - Trends in Biochemical Sciences
IS - 3
ER -